Perelman Center for Advanced Medicine (PCAM) Hospital of The University of Pennsylvania Penn Blood Disorders Program is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.
Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.
Perelman Center for Advanced Medicine (PCAM) Hospital of The University of Pennsylvania Penn Blood Disorders Program has participated in 2 clinical trials with 2 currently active.
Therapeutic areas: Immune Thrombocytopenic Purpura (ITP).
Sponsors: Takeda.
Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Perelman Center for Advanced Medicine (PCAM) Hospital of The University of Pennsylvania Penn Blood Disorders Program has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Perelman Center for Advanced Medicine (PCAM) Hospital of The University of Pennsylvania Penn Blood Disorders Program has 2 clinical trials on record, with 2 currently active. Their work covers Immune Thrombocytopenic Purpura (ITP).
Perelman Center for Advanced Medicine (PCAM) Hospital of The University of Pennsylvania Penn Blood Disorders Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.